About Novelgen
Novelgen is a biotech company focused on research and development, possessing innovative materials and original technologies for the prevention and treatment of viruses.
Novelgen focuses on building an international collaborative research system centered around the broad-spectrum antiviral treatment substance NVG308 and the next-generation biogenic material PATA-X, aiming to achieve a world without viral diseases.
🔬
Innovative Materials
functional raw material PATA-X based on biogenic engineering
🧬
Core Technology
Nucleic acid hydrolyzing mini-antibody NVG308
🌐
Global Collaboration
Joint research with international universities and institutes
